About L & C Bio
L & C Bio is a company based in Seongnam-si (South Korea) founded in 2011. The company has 135 employees as of December 31, 2024. L & C Bio operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Seongnam-si, South Korea
- Employees 135 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name L&C Bio Co., Ltd.
-
Annual Revenue
$48.88 M (USD)9.35as on Dec 31, 2024
-
Net Profit
$95.64 M (USD)191.69as on Dec 31, 2024
-
EBITDA
$5.75 M (USD)-33.26as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
135
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of L & C Bio
L & C Bio is a publicly listed company on the KRX with ticker symbol 290650 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of L & C Bio
Detailed funding history for L C Bio
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by L & C Bio
Investment portfolio details for L C Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - L C Bio
Detailed financials for L C Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
L & C Bio Comparisons
Peer comparison for L C Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of L & C Bio
L & C Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of L C Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on L & C Bio
Complete news archive for L C Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about L & C Bio
L & C Bio was founded in 2011.
L & C Bio is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
As of Dec 31, 2024, the latest employee count at L & C Bio is 135.
Annual revenue of L & C Bio is $48.88M as on Dec 31, 2024.
L C Bio was founded in 2011 and is based in Seongnam-si, South Korea. Allograft and xenograft solutions are developed across tissue engineering, medical devices, and cosmeceuticals. Manufacturing facilities are certified under ISO 9001 and GMP standards. Biomaterials for tissue repair, collagen-based supplements, implantable biomaterial bones, deep wound coverings, and bioabsorbable wound materials are produced. Operations focus on biomedical innovations for implantation and repair applications.
L & C Bio's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Yes, L & C Bio is publicly traded on KRX under the ticker symbol 290650.
The ticker symbol of L & C Bio is 290650 on KRX.